What is LOPJLB’s current signal on ATTO?

LOPJLB’s latest quantitative signal on Attovia Therapeutics, Inc. (ATTO) is SELL. Signals are updated daily.

What market regime is ATTO in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Attovia Therapeutics, Inc. (ATTO) do?

A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory dise…

Where is Attovia Therapeutics, Inc. based / listed?

Attovia Therapeutics, Inc. is based in US, listed on NASDAQ.

Attovia Therapeutics, Inc. (ATTO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$18.00+4.83%Close

SELL

[SCORES & PROFILE]

FUND: 0
VALUE: 3
GROWTH: 4
GARP: 3
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-19.2%

REV YoY-

ROE-32.1%

EPS YoY-

ROA-30.7%

GROSS

-8

-9280

NET

-8743

[VALUATION]

P/E TTM-19.35

P/E FWD-

SECTOR PE20.58

INDUSTRY PE13.91

P/B7.28

P/FCF-

EV/EBITDA-18.07

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E3.84

ALTMAN Z-

CURR RATIO9.39

ND/EBITDA-

BETA0.00

Attovia Therapeutics, Inc. (ATTO)

Key stats

Prediction markets

FUNDAMENTALS

Company news